Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45(4):846–54. https://www.ncbi.nlm.nih.gov/pubmed/17393509
Boursier J, Guillaume M, Leroy V, Irles M, Roux M, Lannes A, et al. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J Hepatol 2019;71(2):389–96. https://www.ncbi.nlm.nih.gov/pubmed/31102719
Majumdar A, Tsochatzis EA. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. Metabolism 2020:154291. https://www.ncbi.nlm.nih.gov/pubmed/32531295
Newsome PN, Cramb R, Davison SM, Dillon JF, Foulerton M, Godfrey EM, et al. Guidelines on the management of abnormal liver blood tests. Gut 2018;67(1):6–19. https://www.ncbi.nlm.nih.gov/pubmed/29122851
Petroff D, Batz O, Jedrysiak K, Kramer J, Berg T, Wiegand J. Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples. Gut 2020. https://www.ncbi.nlm.nih.gov/pubmed/32245907
Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 2011;53(2):190–5. https://www.ncbi.nlm.nih.gov/pubmed/21788761
Srivastava A, Gailer R, Tanwar S, Trembling P, Parkes J, Rodger A, et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol 2019;71(2):371–8. https://www.ncbi.nlm.nih.gov/pubmed/30965069
Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43(6):1317–25. https://www.ncbi.nlm.nih.gov/pubmed/16729309
Tsai E, Lee TP. Diagnosis and evaluation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography. Clin Liver Dis 2018;22(1):73–92. https://www.ncbi.nlm.nih.gov/pubmed/29128062
Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol 2018;68(2):305–15. https://www.ncbi.nlm.nih.gov/pubmed/29154965
